SARCULATOR vs IOTOX Algorithm
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
SARCULATOR
This medical tool provides physicians with predictive models for retroperitoneal and extremity sarcoma patients. It estimates overall survival and disease-free survival, serving as an informative resource to enhance physician predictive capabilities.
- Predictive models for sarcoma patients
- Estimates 5-year overall survival
- Estimates 5-year disease-free survival
- Estimates 10-year overall survival
- Estimates cumulative incidence of distant metastasis
- Informative tool for physicians
Read full descriptionHide full description
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - ESTS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
IOTOX Algorithm
Read full descriptionHide full description
Immunotherapies have become essential in treating advanced malignancies. However, immunotherapies can attack healthy cells, leading to toxicities or side effects. To address how to best treat patients with these toxicities, the Internal Medicine division has collaborated with the Cancer Medicine division, as well as other divisions at MD Anderson, to create the Immuno-Oncology Toxicity (IOTOX) Leaders Group. Clinical management algorithms depict best practices for evaluating, diagnosing, and treating specific conditions that arise during the course of cancer treatment. These algorithms are not intended to replace the independent medical judgment of the physician in the context of individual clinical circumstances to determine a patient's care.
Screenshots
Verdict
The clearest difference is update cadence: IOTOX Algorithm at every 6 weeks against SARCULATOR's every 7 months. SARCULATOR's advantage is device support (3 vs 1) and iOS requirement (13.0 vs 18.0). On price, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
SARCULATOR ships an update every 7 months, IOTOX Algorithm every 6 weeks. The most recent releases landed on September 21, 2026 and September 18, 2026 respectively.
| Parameter | SARCULATOR | IOTOX Algorithm |
|---|---|---|
| Price | Free | Free |
| Rating | 4.3 (3 ratings) — better | — |
| Number of ratings | 3 — better | — |
| Update frequency | Every 7 months | Every 6 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod — better | iPhone |
| Requires iOS | 13.0 — better | 18.0 |
| Further details — not scored | ||
| Size | 26 MB | 7 MB |
| Age rating | 12+ | 17+ |
| Developer | DIGITAL FOREST SRL | MD Anderson Cancer Center |
In-app purchases
SARCULATOR
No in-app purchases
IOTOX Algorithm
No in-app purchases
Questions
Is SARCULATOR free?
Is IOTOX Algorithm free?
Do SARCULATOR or IOTOX Algorithm have ads?
Which is updated more often, SARCULATOR or IOTOX Algorithm?
Other comparisons
